WallStreetZenWallStreetZen

NASDAQ: CNTX
Context Therapeutics Inc Stock Ownership - Who owns Context Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Context Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Martin A. LehrChief Executive Officer2023-02-215,823$0.84
$4.90kBuy
Martin A. LehrChief Executive Officer2023-02-135,606$0.87
$4.90kBuy
Martin A. LehrChief Executive Officer2023-02-065,040$0.97
$4.90kBuy
Martin A. LehrChief Executive Officer2023-01-307,027$0.70
$4.90kBuy
Martin A. LehrChief Executive Officer2023-01-236,839$0.72
$4.90kBuy
Martin A. LehrChief Executive Officer2023-01-176,783$0.74
$4.99kBuy
Jennifer Lynn MinaiazaryChief Financial Officer2022-12-1625,000$0.74
$18.50kBuy
Martin A. LehrChief Executive Officer2022-12-1620,000$0.74
$14.80kBuy
Alex C. LevitChief Legal Officer Corp. Sec2022-12-096,000$0.85
$5.09kBuy
Martin A. LehrChief Executive Officer2022-08-1913,000$1.85
$24.06kBuy

1 of 2

CNTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTX insiders and whales buy or sell their stock.

CNTX Shareholders

What type of owners hold Context Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Martin A. Lehr6.14%979,891$862.30kInsider
Vanguard Group Inc3.59%573,400$504.59kInstitution
Hightower Advisors LLC0.79%125,852$110.75kInstitution
Bridgeway Capital Management LLC0.66%105,809$93.11kInstitution
Mill Creek Capital Advisors LLC0.66%104,631$92.08kInstitution
Alex C. Levit0.39%61,983$54.55kInsider
Geode Capital Management LLC0.37%59,568$52.42kInstitution
Evan G. Dick0.35%56,373$49.61kInsider
Two Sigma Investments LP0.35%55,688$49.01kInstitution
Virtu Financial LLC0.26%41,191$36.25kInstitution

1 of 3

CNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTX8.06%7.22%Net Buying
TCON10.51%89.49%Net BuyingNet Buying
PHGE13.82%34.65%Net SellingNet Buying
INFI21.48%22.42%Net Buying
ACGN0.18%99.82%Net BuyingNet Selling
View Top Biotech Stocks

Context Therapeutics Stock Ownership FAQ

Who owns Context Therapeutics?

Context Therapeutics (NASDAQ: CNTX) is owned by 8.06% institutional shareholders, 7.22% Context Therapeutics insiders, and 84.72% retail investors. Martin A. Lehr is the largest individual Context Therapeutics shareholder, owning 979,891.00 shares representing 6.14% of the company. Martin A. Lehr's Context Therapeutics shares are currently valued at $862.30k.

If you're new to stock investing, here's how to buy Context Therapeutics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.